Arbutus Biopharma Corp insider trading activity

Understanding Insider Activity at Arbutus Biopharma Corp

Welcome to our dedicated page for Arbutus Biopharma Corp (Nasdaq: ABUS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Arbutus Biopharma Corp's key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Arbutus Biopharma Corp, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for ABUS
TickerTime & DateFilingLink
ABUS12:55:02 AM 2/6/2024
Sims Karen(Chief Medical Officer) sold 4358 shares of Arbutus Biopharma Corp (ABUS) for ~$10066
ABUS12:54:49 AM 2/6/2024
HASTINGS DAVID C(Chief Financial Officer) sold 9593 shares of Arbutus Biopharma Corp (ABUS) for ~$22159
ABUS12:54:25 AM 2/6/2024
Sofia Michael J.(Chief Scientific Officer) sold 9982 shares of Arbutus Biopharma Corp (ABUS) for ~$23058
ABUS12:54:09 AM 2/6/2024
McElhaugh Michael J.(Interim President & CEO) sold 10164 shares of Arbutus Biopharma Corp (ABUS) for ~$23478